
Mycoplasma Genitalium Real Time PCR Kit
Jiangsu Bioperfectus Technologies Co., Ltd. display-approved product profile.
Product Catalog
Browse indexed product records. Filter by family, platform, application, and throughput, then request a quote with full product context.
Select or search to build a workflow in minutes.
Refine below by family, platform, and application. Your filter stack stays in the URL for sharing.

Jiangsu Bioperfectus Technologies Co., Ltd. display-approved product profile.

Jiangsu Bioperfectus Technologies Co., Ltd. display-approved product profile.

Roche Diagnostics display-approved product profile.

cobas® HPV is a qualitative nucleic acid test from Roche Diagnostics, listed for HPV. Stated instrument compatibility: cobas® 5800, cobas® 6800, cobas® 8800. Registration status and availability vary by market.
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.
UC-TIB-HPV-GT (HPV31/33/45/52/58) is a nucleic acid test from Roche Diagnostics, listed for HPV. Registration status and availability vary by market.
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.

High Risk Human Papillomavirus Multiplex Kit is a nucleic acid test from Novacyt (Primerdesign), listed for HPV. Registration status and availability vary by market.
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.

VitaSIRO solo™ HPV Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Request confirmation of sample compatibility, regulatory position, service model, and supply continuity before issuing an RFQ.